Prescription ID | TCMF4046 |
Pinyin Name | Huan Shao Jiao Nang |
Chinese Name | 还少胶囊 |
English Name | Huan Shao Capsules |
Function Description | 阳痿, 遗精, 耳鸣, 眩晕 |
Indications | Involuntary ejaculation disorder, Impotence disorder, Tinnitus disorder, Vertigo disorder, Tinnitus, Dizziness, Sexual dysfunction |
Disease ICD-11 Category |
SB09 [Involuntary ejaculation disorder (TM1), 遗精 (TM1)
]; SB0B [Impotence disorder (TM1), 阳痿 (TM1) ]; SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1) ]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; MC41 [Tinnitus, 耳鸣 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; HA0Z [Sexual dysfunctions, unspecified, 性功能障碍,未特指的 ]; |
Human Tissues Associated with Indication | Brain, Kidney |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
TCMH1845 | Dioscorea batatas | 山药 | TCMH1845 | |
TCMH1588 | Achyranthes bidentata | 牛膝 | TCMH1588 | ITSAJ4612-14 |
TCMH1186 | Lycium chinense | 枸杞子 | TCMH1186 | ITSAO4545-14 |
TCMH1862 | Cornus officinalis | 山茱萸 | TCMH1862 | ITSAO2979-14 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH524 | Eucommia ulmoides | 杜仲 | TCMH524 | ITSAM1588-14 |
TCMH2554 | Polygala tenuifolia | 远志 | TCMH2554 | MF096619 |
TCMH31 | Morinda officinalis | 巴戟天 | TCMH31 | ITSAJ4459-14 |
TCMH2202 | Schisandra chinensis | 五味子 | TCMH2202 | ITSAM2867-14 |
TCMH2295 | fructus foeniculi | 小茴香 | TCMH2295 | |
TCMH269 | Fructus broussonetiae | 楮实子 | TCMH269 | |
TCMH1740 | Cistanche deserticola | 肉苁蓉 | TCMH1740 | ITSAM2511-14 |
TCMH1920 | Acorus tatarinowii | 石菖蒲 | TCMH1920 | ITSAI4409-14 |
TCMH388 | Ziziphus jujuba | 大枣 | TCMH388 | ITSAM869-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT107 | GRIK2 | Glutamate receptor ionotropic kainate 2 | Ion channel | Q13002 |
TCMT109 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | Ion channel | P42262 |
TCMT110 | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | Ion channel | P48058 |
TCMT111 | GRIK5 | Glutamate receptor ionotropic kainate 5 | Ion channel | Q16478 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT290 | CHRM5 | Muscarinic acetylcholine receptor M5 | GPCR | P08912 |
TCMT291 | CHRM3 | Muscarinic acetylcholine receptor M3 | GPCR | P20309 |
TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT34 | CYP2D6 | Cytochrome P450 2D6 | Oxidoreductase | P10635 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT594 | PTAFR | Platelet activating factor receptor | GPCR | P25105 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT632 | PNP | Purine nucleoside phosphorylase | Transferase | P00491 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT649 | DRD5 | Dopamine D5 receptor | GPCR | P21918 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT651 | DRD3 | Dopamine D3 receptor | GPCR | P35462 |
TCMT653 | GRM1 | Metabotropic glutamate receptor 1 | GPCR | Q13255 |
TCMT654 | GRM5 | Metabotropic glutamate receptor 5 | GPCR | P41594 |
TCMT655 | GRM2 | Metabotropic glutamate receptor 2 | GPCR | Q14416 |
TCMT656 | GRM3 | Metabotropic glutamate receptor 3 | GPCR | Q14832 |
TCMT657 | GRM4 | Metabotropic glutamate receptor 4 | GPCR | Q14833 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT660 | GRM8 | Metabotropic glutamate receptor 8 | GPCR | O00222 |
TCMT664 | SLC1A1 | Excitatory amino acid transporter 3 | Transporter | P43005 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT771 | ATR | Serine-protein kinase ATR | Kinase | Q13535 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT81 | ALOX12 | Arachidonate 12-lipoxygenase | Oxidoreductase | P18054 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
Target ID | Target Name |
---|---|
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1250 | Vesicular stomatitis virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1282 | Colletotrichum orbiculare |
TCMT1286 | Bacillus cereus |
TCMT1293 | Vaccinia virus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1321 | Staphylococcus hominis |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1354 | Streptococcus mutans UA159 |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1390 | Human herpesvirus 2 strain G |
TCMT1393 | Vibrio sp. |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, PTAFR, SLC1A1, SMAD3, SRC, TEK, TRPV1, XDH | 14.5732 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, PTAFR, RORC, SRC, TEK, TRPV1, TYR | 12.3803 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TRPV1, TYR | 12.15 |
[BP] GO:0007193 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8 | 10.6413 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TRPV1, TYR | 10.2107 |
[BP] GO:0007188 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GRM1, GRM3, GRM5, GRM8 | 9.99634 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F10, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TRPV1, TYR | 9.98409 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, MET, PPARA, TRPV1 | 9.75935 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 9.6435 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PTAFR, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TRPV1, XDH | 9.56206 |
[BP] GO:0007187 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GRM1, GRM3, GRM5, GRM8 | 9.25702 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 9.1066 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 9.0787 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 9.04893 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FLT3, NR3C1, PTAFR, RORC, SRC, TEK, TRPV1, TYR | 9.04893 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 8.88656 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 8.61847 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 8.54322 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, PTAFR, SMAD3, SRC, TEK, XDH | 8.51115 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, DRD1, DRD5, EGFR, ESR1, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, NR3C1, PPARA, PTAFR, SMAD3, SRC, TEK, TRPV1 | 8.407 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, GRIK5, GRM5, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, TRPV1 | 8.26128 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 8.25259 |
[BP] GO:0007268 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 8.09631 |
[BP] GO:0098916 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 8.09631 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PTAFR, RORC, SMAD3, SRC, TRPV1 | 8.0002 |
[BP] GO:0099536 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 8.0002 |
[BP] GO:0099537 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 8.0002 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.98087 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.98087 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, HMGCR, HSD11B1, HSD17B1, HSD17B2 | 7.91454 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, ALOX12, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 7.61065 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH | 7.55758 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, MMP2, NR3C1, PTAFR, RORC, SMAD3, SRC, TRPV1 | 7.53965 |
[BP] GO:0007200 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, ESR1, GRM5 | 7.43601 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, ALOX12, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC, TRPV1 | 7.34907 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, DRD1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8 | 7.34907 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA6, CA7, CA9 | 7.32693 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, ALOX12, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, TRPV1 | 7.20623 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH | 7.164 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH | 7.13558 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 | 7.06963 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, ALOX12, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 7.0313 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH | 6.98573 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, PTAFR, TEK | 6.91338 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, TYR | 6.78898 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FUT7, HMGCR, HSPA1A, PIM1, PPARA, PTAFR, TYR, XDH | 6.78898 |
[BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH | 6.78898 |
[BP] GO:0007215 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 6.77349 |
[BP] GO:0007267 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK | 6.73373 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, ALOX12, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 6.63845 |
[BP] GO:0003018 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, PTAFR, SRC, TEK | 6.61233 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH | 6.58026 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 6.53534 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PTAFR, PTPN1, RORC, SMAD3, SRC, TRPV1 | 6.53534 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD2, DRD3, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH | 6.52247 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, NR3C1, PPARA, PTAFR, SRC, TEK, TRPV1 | 6.4634 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, AXL, CYP1B1, DRD1, DRD5, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, NR3C1, PTAFR, RORC, SRC, TRPV1 | 6.46317 |
[BP] GO:0007197 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.46317 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, HMGCR, PTAFR, TYR | 6.44144 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PTAFR, SRC, TEK, TRPV1, TYR | 6.41165 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR | 6.40766 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC1A1, TRPV1 | 6.40239 |
[BP] GO:0007154 | None | ADORA1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK, TRPV1 | 6.34855 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FLT3, NR3C1, PTAFR, RORC, SRC, TRPV1 | 6.33224 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2 | 6.27837 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 6.2254 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 6.2254 |
[BP] GO:0044057 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, DRD3, EGFR, GPR35, GRM1, HCAR2, PTAFR, SLC1A1, SMAD3, TRPV1 | 6.17831 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, ALOX12, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 6.17831 |
[BP] GO:0023052 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK | 6.16903 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, GRM1, HMGCR, HSPA1A, MMP2, PPARA, PTAFR, SMAD3, SRC, TEK, TRPV1, TYR | 6.15955 |
[BP] GO:0030335 | positive regulation of cell migration | ALOX12, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 6.14584 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 6.13527 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, TYR, XDH | 6.12299 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, TRPV1 | 6.09827 |
[BP] GO:0007207 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.07823 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2 | 6.02015 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD17B2, NR3C1, PTAFR, RORC, SRC, TYR | 5.99238 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PTAFR, SRC, TEK, TRPV1, TYR | 5.98177 |
[BP] GO:2000147 | positive regulation of cell motility | ALOX12, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 5.98177 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, HMGCR, KDR, NR3C1, PTAFR, SRC, TRPV1 | 5.87535 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, ESR1, FABP4, GPR35, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC | 5.85237 |
[BP] GO:0051272 | positive regulation of cellular component movement | ALOX12, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 5.843 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRIK5, INSR, SLC1A1, SMAD3, TRPV1 | 5.81814 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 5.81407 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK | 5.80682 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, HMGCR, MET, PPARA | 5.71543 |
[BP] GO:0040017 | positive regulation of locomotion | ALOX12, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTAFR, SMAD3, SRC, TEK | 5.66704 |
[BP] GO:0003013 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, PTAFR, SRC, TEK | 5.64272 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK | 5.64272 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, ALOX15, AXL, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, GRIK5, GRM5, HCAR2, HMGCR, HSPA1A, INSR, MMP9, PPARA, PTAFR, PTPN1, SMAD3, SRC, TRPV1 | 5.59832 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 5.56857 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 5.53241 |
[BP] GO:0045776 | None | ADORA1, DRD2, DRD3, DRD5, PPARA, PTAFR | 5.47055 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 5.46491 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CHRM5, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HMGCR, PPARA, RORC, SRC, TEK | 5.28538 |
[BP] GO:0007196 | None | GRM1, GRM3, GRM5, GRM8 | 5.25002 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TRPV1, XDH | 5.18941 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA3, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, HCAR2, INSR, PTAFR, SRC | 5.17427 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, AURKB, CDC25B, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 5.16064 |
[BP] GO:0097746 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, PTAFR | 5.14011 |
[BP] GO:0035296 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, PTAFR | 5.14011 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC1A1, TRPV1 | 5.12836 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR, HMGCR | 5.11917 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC | 5.08922 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TYR, XDH | 5.08056 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, CYP1A1, DRD2, DRD5, EGFR, PPARA, SMAD3 | 5.0765 |
[BP] GO:2001225 | regulation of chloride transport | CA2, CA7, GRM5, PTAFR | 5.06456 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK | 5.02821 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, HMGCR, KDR, SRC, TRPV1 | 4.97032 |
[BP] GO:0050880 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, PTAFR | 4.96203 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 4.95431 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 4.9453 |
[BP] GO:0035150 | None | ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, PTAFR | 4.9453 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 4.90631 |
[BP] GO:0050801 | ion homeostasis | CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 4.89868 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 4.88602 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, HMGCR, KDR, SRC | 4.87784 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX12, ALOX15, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 4.86157 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, PPARA, SMAD3, TEK | 4.8099 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, DRD1, DRD5, EGFR, ESR1, FLT3, GRM5, IGF1R, INSR, MMP2, NR3C1, PTAFR, SMAD3, SRC, TRPV1 | 4.79893 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH | 4.77957 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 4.765 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, ALOX12, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PIM1, PTAFR, SLC1A1, SMAD3, SRC, TEK, TRPV1, XDH | 4.72777 |
[BP] GO:0003008 | None | ADORA1, AKR1B1, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, GRM1, GRM5, GRM8, HMGCR, INSR, PTAFR, SRC, TEK, TRPV1, TYR | 4.72777 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 4.69938 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TYR | 4.6728 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, DRD2, EGFR, FLT3, GRM1, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.66491 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | ALOX12, AXL, CA2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, F3, HCAR2, HMGCR, HSPA1A, KDR, MET, MMP9, PIM1, PTAFR, SLC1A1, SMAD3, SRC, TEK, TRPV1 | 4.65537 |
[BP] GO:0050890 | None | ADORA1, CHRM1, DRD1, DRD2, DRD3, DRD5, EGFR, GRM5, HMGCR, INSR | 4.63769 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTAFR, PTPN1, SRC, TEK, XDH | 4.63255 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH | 4.61663 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 | 4.61663 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC, TRPV1 | 4.61272 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH | 4.60082 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F10, F3, INSR, MET, SRC, TEK | 4.5698 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ALOX15, DRD2, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.5698 |
[BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, DRD1, DRD2, DRD3, HMGCR, PPARA, SMAD3, TEK | 4.5604 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, HSPA1A | 4.53454 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 4.53096 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, NR3C1, PTAFR, SRC, TRPV1 | 4.52469 |
[BP] GO:0007216 | None | GRM1, GRM3, GRM5, GRM8 | 4.50435 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR | 4.48806 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR | 4.4557 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, ALOX12, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 4.39569 |
[BP] GO:0098771 | inorganic ion homeostasis | CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 4.3878 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, HMGCR, PTAFR, TYR | 4.38525 |
[BP] GO:0001963 | None | DRD1, DRD2, DRD3, DRD5 | 4.38495 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TYR | 4.38381 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 4.34065 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ALOX15, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 4.3117 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTAFR, PTPN1, SRC, TEK, XDH | 4.30982 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR | 4.30933 |
[BP] GO:0007213 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.27709 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH | 4.21793 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, GRM3, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 4.21105 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, ALOX12, DRD1, DRD2, MET, TRPV1 | 4.19945 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TRPV1, TYR, XDH | 4.18659 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ALOX15, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 4.18582 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, XDH | 4.16311 |
[BP] GO:0050877 | None | ADORA1, CHRM1, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, GRM1, GRM5, GRM8, HMGCR, INSR, TRPV1, TYR | 4.15737 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, DRD1, DRD5, EGFR, GRM5, IGF1R, INSR, MMP2, PTAFR, SRC, TRPV1 | 4.14767 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTAFR | 4.11825 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ALOX15, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 4.11297 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 4.09173 |
[BP] GO:0060078 | None | ADORA1, GRIA2, GRIA4, GRIK5, GRM5, TRPV1 | 4.09069 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 | 4.02958 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK | 4.01612 |
[BP] GO:0006811 | None | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM5, DRD1, DRD2, DRD3, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1, TRPV1 | 3.94152 |
[BP] GO:0072507 | divalent inorganic cation homeostasis | DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.92958 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX12, ALOX15, ALOX5 | 3.87614 |
[BP] GO:0016098 | monoterpenoid metabolic process | CYP1A2, CYP2D6, CYP3A4 | 3.87614 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | DRD2, DRD3, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH | 3.87309 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, PTPN1, SRC | 3.87172 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ALOX15, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 3.86311 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 3.85866 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, DRD1, DRD5, EGFR, GRM5, IGF1R, INSR, MMP2, PTAFR, SRC, TRPV1 | 3.84923 |
[BP] GO:0007612 | None | DRD1, DRD2, DRD3, DRD5, GRM5, HMGCR, INSR | 3.84232 |
[BP] GO:0044093 | positive regulation of molecular function | ADORA1, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, MMP9, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 3.84232 |
[BP] GO:0055080 | cation homeostasis | CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.79323 |
[BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, AXL, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, HCAR2, INSR, PTAFR, SMAD3, SRC, TRPV1 | 3.78336 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK | 3.77129 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ALOX15, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH | 3.74846 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, DRD2, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK | 3.74761 |
[BP] GO:0095500 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.6871 |
[BP] GO:1903831 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.6871 |
[BP] GO:0050794 | regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 3.67685 |
[BP] GO:0009820 | alkaloid metabolic process | CYP1A2, CYP2D6, CYP3A4 | 3.67365 |
[BP] GO:0009410 | None | DRD1, DRD2, DRD3, DRD5, EGFR, NR3C1, PTAFR | 3.66126 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 3.65018 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 3.63419 |
[BP] GO:0048511 | rhythmic process | AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, PPARA, RORC, SRC | 3.63419 |
[BP] GO:0055082 | cellular chemical homeostasis | CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3, TRPV1 | 3.63193 |
[BP] GO:1903522 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, EGFR, PTAFR, SLC1A1 | 3.62694 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.62694 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 | 3.62333 |
[BP] GO:0008217 | None | ADORA1, DRD2, DRD3, DRD5, PPARA, PTAFR, SMAD3 | 3.61817 |
[BP] GO:0050789 | regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TRPV1, XDH | 3.56607 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 3.56455 |
[BP] GO:0030817 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8 | 3.561 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK | 3.52808 |
[BP] GO:0030003 | cellular cation homeostasis | CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.52372 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 3.5182 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2D6 | 3.5182 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA | 3.51474 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK | 3.51011 |
[BP] GO:0051940 | None | DRD1, DRD2, DRD3 | 3.51011 |
[BP] GO:0051584 | None | DRD1, DRD2, DRD3 | 3.51011 |
[BP] GO:0001975 | None | DRD1, DRD2, DRD3, DRD5 | 3.50987 |
[BP] GO:0006874 | cellular calcium ion homeostasis | DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.5096 |
[BP] GO:0051047 | None | ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, PTAFR, SRC, TRPV1 | 3.50114 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PTPN1, SRC | 3.48557 |
[BP] GO:0072593 | reactive oxygen species metabolic process | ALOX12, CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR | 3.48439 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 3.48385 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 3.48385 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 | 3.46186 |
[BP] GO:0007271 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.45437 |
[BP] GO:0006873 | cellular ion homeostasis | CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.4462 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP4, GRM3, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH | 3.4363 |
[BP] GO:0055074 | calcium ion homeostasis | DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.40805 |
[BP] GO:0072503 | cellular divalent inorganic cation homeostasis | DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.36528 |
[BP] GO:1900542 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8, INSR, PPARA | 3.36528 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 3.36212 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ALOX15, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 3.36051 |
[BP] GO:0007611 | None | DRD1, DRD2, DRD3, DRD5, EGFR, GRM5, HMGCR, INSR | 3.35882 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ALOX15, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 3.35882 |
[BP] GO:0042391 | None | ADORA1, DRD1, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC, TRPV1 | 3.35882 |
[BP] GO:0050878 | regulation of body fluid levels | ADORA1, AKR1B1, ALOX12, CHRM1, CHRM3, DRD2, F10, F3, MET, XDH | 3.35882 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPL, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TYR, XDH | 3.34599 |
[BP] GO:0006468 | protein phosphorylation | AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.34477 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, DRD1, DRD2, DRD5 | 3.30331 |
[BP] GO:0006140 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8, INSR, PPARA | 3.29169 |
[BP] GO:0006940 | None | ADORA1, CHRM1, CHRM2, CHRM3, PTAFR | 3.27433 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, EGFR, MMP2, MMP9, TEK | 3.2487 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, RORC | 3.2487 |
[BP] GO:0001659 | None | ADORA1, DRD1, DRD2, TRPV1 | 3.24538 |
[BP] GO:0007191 | None | DRD1, DRD3, DRD5 | 3.23971 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.23971 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, NR3C1, PIM1, PPARA, RORC, SRC | 3.2384 |
[BP] GO:0030814 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8 | 3.21237 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, DRD2 | 3.19589 |
[BP] GO:1901654 | None | AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, PTAFR, SRC | 3.19438 |
[BP] GO:0060079 | None | ADORA1, GRIA2, GRIA4, GRIK5, TRPV1 | 3.1605 |
[BP] GO:0030802 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8 | 3.15568 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3 | 3.13702 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, CA2, CA7, DRD1, DRD2, EGFR | 3.11695 |
[BP] GO:1900543 | None | DRD2, DRD3, GRM3, GRM8, PPARA | 3.10776 |
[BP] GO:0008306 | None | DRD1, DRD2, DRD3, DRD5, HMGCR | 3.10776 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.09202 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | CHRM5, FABP3, FLT3, SRC, TEK | 3.0861 |
[BP] GO:0045980 | None | DRD2, DRD3, GRM3, GRM8, PPARA | 3.0861 |
[BP] GO:0021885 | forebrain cell migration | AXL, DRD1, DRD2, EGFR | 3.05753 |
[BP] GO:0007610 | None | DRD1, DRD2, DRD3, DRD5, EGFR, GRM1, GRM5, HMGCR, INSR, PPARA, TRPV1 | 3.04147 |
[BP] GO:1901652 | response to peptide | AKR1B1, FABP3, GRM5, IGF1R, INSR, PPARA, SRC, TEK, TRPV1 | 3.0299 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, TYR, XDH | 3.02666 |
[BP] GO:0070989 | oxidative demethylation | CYP1A2, CYP2D6, CYP3A4 | 3.0112 |
[BP] GO:0055065 | metal ion homeostasis | DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 3.0112 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, TYR, XDH | 3.0112 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 3.0112 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTAFR | 3.00031 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC, TEK | 2.99272 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 2.98498 |
[BP] GO:1900371 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8 | 2.98498 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 | 2.98274 |
[BP] GO:0007212 | None | DRD1, DRD2, DRD3, DRD5 | 2.9779 |
[BP] GO:0032467 | None | AURKB, CDC25B, DRD2, DRD3 | 2.9779 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, NR3C1, PPARA, RORC, SRC | 2.97236 |
[BP] GO:0030808 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8 | 2.97236 |
[BP] GO:0042060 | None | ALOX15, DRD5, EGFR, PPARA, SMAD3 | 2.97221 |
[BP] GO:0046717 | None | CHRM5, DRD2, DRD3, SLC1A1, TRPV1 | 2.97221 |
[BP] GO:0046960 | None | DRD1, DRD5 | 2.97221 |
[BP] GO:2001301 | lipoxin biosynthetic process | ALOX12, ALOX15 | 2.97221 |
[BP] GO:2001302 | lipoxin A4 metabolic process | ALOX12, ALOX15 | 2.97221 |
[BP] GO:2001303 | lipoxin A4 biosynthetic process | ALOX12, ALOX15 | 2.97221 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, DRD2, EGFR, HMGCR, KDR, SRC, TEK | 2.96007 |
[BP] GO:0018958 | None | AKR1B1, DRD1, DRD2, DRD3, TYR | 2.95094 |
[BP] GO:0014075 | None | DRD1, DRD2, DRD3, DRD5 | 2.94869 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.93132 |
[BP] GO:0060134 | None | DRD1, DRD2, DRD3 | 2.93132 |
[BP] GO:0060158 | None | DRD1, DRD2, DRD5 | 2.93132 |
[BP] GO:0019725 | cellular homeostasis | CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3, TRPV1 | 2.91644 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK | 2.91188 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK | 2.88764 |
[BP] GO:0090066 | None | ADORA1, ALOX15, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, PTAFR | 2.88307 |
[BP] GO:0046903 | None | ALOX5, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, HSPA1A, MMP9, PTAFR, SLC1A1, TRPV1, XDH | 2.87631 |
[BP] GO:0045787 | positive regulation of cell cycle | AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC | 2.86821 |
[BP] GO:0044070 | regulation of anion transport | ADORA1, CA2, CA7, GRM5, PTAFR | 2.86346 |
[BP] GO:0051480 | regulation of cytosolic calcium ion concentration | DRD1, DRD2, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 2.85147 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.84427 |
[BP] GO:0051580 | None | DRD1, DRD2, DRD3 | 2.84427 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC, TEK | 2.84427 |
[BP] GO:1904407 | positive regulation of nitric oxide metabolic process | EGFR, INSR, SMAD3, TRPV1 | 2.83841 |
[BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | EGFR, INSR, SMAD3, TRPV1 | 2.83841 |
[BP] GO:0030799 | None | DRD1, DRD2, DRD3, DRD5, GRM3, GRM8 | 2.79512 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK | 2.79512 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ALOX15, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTAFR, PTPN1, SMAD3, SRC, TEK, XDH | 2.78446 |
[BP] GO:0006584 | None | AKR1B1, DRD1, DRD2, DRD3 | 2.76227 |
[BP] GO:0009712 | None | AKR1B1, DRD1, DRD2, DRD3 | 2.76227 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 2.76227 |
[BP] GO:0006875 | cellular metal ion homeostasis | DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GRM1, GRM5, SMAD3, TRPV1 | 2.74749 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ALOX15, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 2.74749 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, ALOX15, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH | 2.73782 |
[BP] GO:0045936 | None | DRD2, DRD3, DUSP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH | 2.7372 |
[BP] GO:0060359 | None | DRD1, DRD2, DRD3, DRD5, PTAFR | 2.73581 |
[BP] GO:0010563 | None | DRD2, DRD3, DUSP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH | 2.7328 |
[BP] GO:0030818 | None | DRD2, DRD3, GRM3, GRM8 | 2.73141 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.7102 |
[BP] GO:0048545 | response to steroid hormone | ALPL, CA2, EGFR, FLT3, NR3C1, PTAFR, SRC | 2.7102 |
[BP] GO:0045761 | None | DRD2, DRD3, DRD5, GRM3 | 2.69738 |
[BP] GO:0097366 | None | DRD1, DRD2, DRD3, DRD5 | 2.69738 |
[BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, INSR, SMAD3, TRPV1, XDH | 2.69738 |
[BP] GO:0009891 | positive regulation of biosynthetic process | AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PTAFR, RORC, SMAD3, SRC, TRPV1 | 2.69738 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.6889 |
[BP] GO:0032225 | None | DRD1, DRD2, DRD3 | 2.6889 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX12, ALOX15, ALOX5 | 2.6889 |
[BP] GO:0030803 | None | DRD2, DRD3, GRM3, GRM8 | 2.6654 |
[BP] GO:0043269 | regulation of ion transport | ADORA1, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, GPR35, GRM5, MMP9, PTAFR | 2.64773 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, PTPN1, SRC | 2.63354 |
[BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, GRM5, IGF1R, INSR, KDR, MET, NUAK1, PTAFR, PTPN1, SRC, TEK | 2.63046 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH | 2.62127 |
[BP] GO:0031960 | response to corticosteroid | ALPL, EGFR, FLT3, NR3C1, PTAFR, SRC | 2.61228 |
[BP] GO:0010638 | positive regulation of organelle organization | ALOX15, AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 2.60826 |
[BP] GO:0008542 | None | DRD1, DRD2, DRD3, HMGCR | 2.60262 |
[BP] GO:0030815 | None | DRD2, DRD3, GRM3, GRM8 | 2.60262 |
[BP] GO:0006939 | None | CHRM3, DRD1, DRD2, TRPV1 | 2.60262 |
[BP] GO:0051046 | None | ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HCAR2, HMGCR, PTAFR, SRC, TRPV1 | 2.59413 |
[BP] GO:1900372 | None | DRD2, DRD3, GRM3, GRM8 | 2.5794 |
[BP] GO:0030809 | None | DRD2, DRD3, GRM3, GRM8 | 2.5794 |
[BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC | 2.5794 |
[BP] GO:0099566 | None | GRM1, GRM5 | 2.5794 |
[BP] GO:0009822 | alkaloid catabolic process | CYP2D6, CYP3A4 | 2.5794 |
[BP] GO:0060160 | None | DRD2, DRD3 | 2.5794 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.5794 |
[BP] GO:0010038 | response to metal ion | ALOX15, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 | 2.56646 |
[BP] GO:0019226 | None | CHRM5, DRD1, DRD5 | 2.55899 |
[BP] GO:0019932 | second-messenger-mediated signaling | DRD1, DRD2, DRD3, DRD5, EGFR, GRM5, KDR | 2.55631 |
[BP] GO:0042752 | None | ADORA1, DRD2, DRD3, PPARA, RORC | 2.55631 |
[BP] GO:0030800 | None | DRD2, DRD3, GRM3, GRM8 | 2.55421 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTAFR, SRC | 2.54407 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 2.50283 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.50283 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.50283 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.50283 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.50283 |
[BP] GO:0045187 | None | ADORA1, DRD2, DRD3 | 2.49986 |
[BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | EGFR, INSR, SMAD3, TRPV1 | 2.49982 |
[BP] GO:0010676 | None | INSR, PPARA, PTAFR, SRC | 2.49982 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, NR3C1, PPARA, RORC, SRC | 2.47454 |
[BP] GO:0007632 | None | DRD1, DRD2, DRD3, HMGCR | 2.47008 |
[BP] GO:0016310 | phosphorylation | AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 2.46428 |
[BP] GO:0071363 | cellular response to growth factor stimulus | EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 | 2.46192 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | CYP1B1, EGFR, INSR, SMAD3, TRPV1, XDH | 2.44983 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.4453 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.4453 |
[BP] GO:0035588 | None | ADORA1, ADORA3, PTAFR | 2.4453 |
[BP] GO:0048148 | None | DRD1, DRD2, DRD3 | 2.4453 |
[BP] GO:0035813 | None | ADORA1, DRD2, DRD3 | 2.4453 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK | 2.43029 |
[BP] GO:0032922 | None | DRD2, DRD3, PPARA, RORC | 2.42019 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.41917 |
[BP] GO:0044283 | None | AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR, PTAFR | 2.40228 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 2.3943 |
[BP] GO:0042749 | None | ADORA1, DRD2, DRD3 | 2.3892 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.3892 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.36672 |
[BP] GO:0045428 | regulation of nitric oxide biosynthetic process | EGFR, INSR, SMAD3, TRPV1 | 2.36672 |
[BP] GO:0009968 | negative regulation of signal transduction | DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH | 2.35213 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, MET, NR3C1, PPARA, PTAFR, RORC, SMAD3, SRC, TRPV1 | 2.35181 |
[BP] GO:0030155 | regulation of cell adhesion | ALOX12, ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK | 2.34811 |
[BP] GO:0051234 | None | ACHE, ADORA1, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, MMP9, PPARA, PTAFR, SLC1A1, SRC, TRPV1, XDH | 2.33863 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.33402 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.33402 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.33402 |
[BP] GO:0070988 | demethylation | CYP1A1, CYP1A2, CYP2D6, CYP3A4 | 2.3218 |
[BP] GO:0051179 | None | ACHE, ADORA1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ESR1, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, MMP9, PPARA, PTAFR, SLC1A1, SRC, TRPV1, XDH | 2.30552 |
[BP] GO:0019229 | None | CHRM1, CHRM3, EGFR, PTAFR | 2.29521 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, EGFR, FLT3, GRM1, INSR, PTPN1, SRC | 2.29521 |
[BP] GO:0071396 | cellular response to lipid | AXL, EGFR, ESR1, FLT3, NR3C1, PTAFR, RORC, SRC | 2.29341 |
[BP] GO:1903530 | regulation of secretion by cell | ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HCAR2, HMGCR, PTAFR, SRC | 2.28999 |
[BP] GO:0044062 | None | ADORA1, DRD2, DRD3 | 2.28951 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.28951 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CYP19A1, PPARA, SMAD3, TEK | 2.28631 |
[BP] GO:0031279 | None | DRD2, DRD3, DRD5, GRM3 | 2.27411 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD5, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK, TRPV1 | 2.26835 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, DRD5, EGFR, ESR1, HSD17B2, INSR, MMP2, MMP9, PTAFR, SRC | 2.2641 |
[BP] GO:0090087 | None | ACHE, ADORA1, CA2, CHRM1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC | 2.25591 |
[BP] GO:0051339 | None | DRD2, DRD3, DRD5, GRM3 | 2.25006 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.24082 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.24082 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH | 2.22754 |
[BP] GO:0010675 | None | INSR, PPARA, PTAFR, RORC, SRC | 2.19382 |
[BP] GO:0050927 | None | F3, KDR, SMAD3 | 2.19359 |
[BP] GO:0007584 | response to nutrient | ALPL, CYP1A1, EGFR, HMGCR, TRPV1, TYR | 2.18734 |
[BP] GO:0006810 | None | ACHE, ADORA1, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, MMP9, PPARA, PTAFR, SLC1A1, SRC, TRPV1, XDH | 2.18654 |
[BP] GO:0022600 | None | CHRM1, CHRM3, CHRM5, DRD3 | 2.18226 |
[BP] GO:0051172 | None | AURKB, CSNK2A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH | 2.17961 |
[BP] GO:0070848 | response to growth factor | EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 | 2.17061 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, SRC, TEK | 2.16818 |
[BP] GO:0032787 | None | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA | 2.16398 |
[BP] GO:0006706 | steroid catabolic process | CYP19A1, CYP1A2, CYP3A4 | 2.15846 |
[BP] GO:0050926 | None | F3, KDR, SMAD3 | 2.15846 |
[BP] GO:0035235 | None | GRIA2, GRIA4, GRIK5 | 2.15846 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.15846 |
[BP] GO:0002009 | morphogenesis of an epithelium | CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.15846 |
[BP] GO:0021853 | None | DRD1, DRD2 | 2.15846 |
[BP] GO:0046541 | None | CHRM1, CHRM3 | 2.15846 |
[BP] GO:0010641 | None | F3, SRC | 2.15846 |
[BP] GO:0090325 | None | DRD2, DRD3 | 2.15846 |
[BP] GO:0007598 | None | F10, F3 | 2.15846 |
[BP] GO:1904936 | None | DRD1, DRD2 | 2.15846 |
[BP] GO:0051122 | hepoxilin biosynthetic process | ALOX12, ALOX15 | 2.15846 |
[BP] GO:0051121 | hepoxilin metabolic process | ALOX12, ALOX15 | 2.15846 |
[BP] GO:0042321 | None | ADORA1, DRD2 | 2.15846 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, SRC, TEK | 2.15215 |
[BP] GO:0015908 | None | DRD2, DRD3, FABP3, PPARA | 2.15126 |
[BP] GO:0051128 | regulation of cellular component organization | ALOX12, ALOX15, AURKB, AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, GRIK5, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK | 2.14492 |
[BP] GO:0044089 | positive regulation of cellular component biogenesis | ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK | 2.13611 |
[BP] GO:0009416 | response to light stimulus | AURKB, DRD1, DRD2, DRD3, EGFR, HMGCR, TYR | 2.13555 |
[BP] GO:0045913 | None | INSR, PPARA, PTAFR, SRC | 2.13119 |
[BP] GO:0032465 | None | AURKB, CDC25B, DRD2, DRD3 | 2.13119 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, HMGCR | 2.10985 |
[BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, MET, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC | 2.1008 |
[BP] GO:0043065 | positive regulation of apoptotic process | CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, SMAD3, SRC, TRPV1, XDH | 2.09178 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK | 2.08967 |
[BP] GO:0031644 | None | ADORA1, GPR35, GRM1, PTAFR | 2.08967 |
[BP] GO:0051482 | None | DRD1, GPR35, GRM1 | 2.08359 |
[BP] GO:0035587 | None | ADORA1, ADORA3, PTAFR | 2.08359 |
[BP] GO:0042417 | None | DRD1, DRD2, DRD3 | 2.08359 |
[BP] GO:0008209 | androgen metabolic process | CYP19A1, CYP3A4, ESR1 | 2.08359 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, F3, MMP9, SMAD3, SRC, XDH | 2.07344 |
[BP] GO:0043068 | positive regulation of programmed cell death | CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, SMAD3, SRC, TRPV1, XDH | 2.06545 |
[BP] GO:0007189 | None | DRD1, DRD2, DRD3, DRD5 | 2.04872 |
[BP] GO:0021843 | None | DRD1, DRD2 | 2.01224 |
[BP] GO:0021830 | None | DRD1, DRD2 | 2.01224 |
[BP] GO:0002933 | lipid hydroxylation | CYP1A1, CYP3A4 | 2.01224 |
[BP] GO:0021826 | None | DRD1, DRD2 | 2.01224 |
[BP] GO:0046958 | None | DRD1, DRD5 | 2.01224 |
[BP] GO:0071383 | None | EGFR, FLT3, NR3C1, SRC | 2.01218 |
[BP] GO:0007623 | circadian rhythm | DRD2, DRD3, EGFR, PPARA, RORC | 2.01092 |
[BP] GO:1901661 | None | AKR1B1, AKR1B10, HMGCR | 2.00854 |
[BP] GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | FLT3, SRC, TEK | 2.00854 |
[BP] GO:0042743 | hydrogen peroxide metabolic process | CYP1A1, CYP1A2, EGFR | 2.00854 |
[CC] GO:0098590 | plasma membrane region | ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, SLC1A1, SRC, TEK, TRPV1 | 9.98409 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, F10, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTAFR, SLC1A1, TEK, TRPV1 | 9.48893 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTAFR, PTPN1, SLC1A1, SMAD3, SRC, TEK, TRPV1 | 9.1066 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, ALOX15, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTAFR, SLC1A1, SRC, TEK, TRPV1 | 8.73691 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTAFR, SLC1A1, TEK, TRPV1 | 7.78799 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTAFR, PTPN1, SLC1A1, SMAD3, SRC, TEK, TRPV1, TYR | 6.97722 |
[CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PTAFR, PTPN1, SLC1A1, SRC, TEK, TRPV1, TYR | 6.68751 |
[CC] GO:0097060 | None | CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, TRPV1 | 6.28187 |
[CC] GO:0044456 | None | ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC, TRPV1 | 5.43575 |
[CC] GO:0045211 | None | CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM3, TRPV1 | 4.5698 |
[CC] GO:0031224 | None | ACHE, ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PTAFR, SLC1A1, TEK, TRPV1, TYR | 4.35261 |
[CC] GO:0044463 | None | ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, GRIA2, GRIA4, GRIK5, GRM3, INSR, SRC, TRPV1 | 3.91219 |
[CC] GO:0120038 | None | ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, GRIA2, GRIA4, GRIK5, GRM3, INSR, SRC, TRPV1 | 3.91219 |
[CC] GO:0014069 | None | ADORA1, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC | 3.81683 |
[CC] GO:0099572 | None | ADORA1, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC | 3.81683 |
[CC] GO:0016021 | None | ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, FUT7, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PTAFR, SLC1A1, TEK, TRPV1, TYR | 3.39359 |
[CC] GO:0042734 | None | GRIK5, GRM1, GRM3, GRM5, GRM8 | 3.35984 |
[CC] GO:0031253 | None | ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC, TRPV1 | 3.34477 |
[CC] GO:0042995 | cell projection | ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD3, DRD5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC, TEK | 3.1033 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, CHRM3, EGFR, TEK | 3.0861 |
[CC] GO:0120025 | None | ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC, TEK | 2.88764 |
[CC] GO:0043005 | None | ADORA1, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC | 2.88223 |
[CC] GO:0043235 | receptor complex | EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 | 2.54407 |
[CC] GO:0098793 | None | ADORA1, CHRM1, CHRM2, CHRM3, DRD2, GRIK5 | 2.48802 |
[CC] GO:0031233 | None | CA4, F10, F3 | 2.4453 |
[CC] GO:0043679 | None | CHRM1, CHRM2, CHRM3, DRD2 | 2.42019 |
[CC] GO:0045202 | None | ACHE, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, GRIA2 | 2.33279 |
[CC] GO:0030054 | cell junction | ACHE, AKR1B1, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, GRIA2, GRIA4, GRIK5, HCAR2, HSPA1A, KDR, TEK, TRPV1 | 2.28746 |
[CC] GO:0043197 | None | ADORA1, DRD2, GRIA2, GRIA4, GRM3 | 2.2407 |
[CC] GO:0044309 | None | ADORA1, DRD2, GRIA2, GRIA4, GRM3 | 2.20987 |
[CC] GO:0097458 | None | ADORA1, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, SRC, TRPV1 | 2.14362 |
[CC] GO:0044306 | None | CHRM1, CHRM2, CHRM3, DRD2 | 2.08967 |
[CC] GO:0044432 | endoplasmic reticulum part | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, EGFR, F10, FLT3, GRIA2, HMGCR, HSD11B1, HSD17B2, PTPN1 | 2.02321 |
[CC] GO:0097443 | sorting endosome | KDR, PTPN1 | 2.01224 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PTAFR, RORC, TEK, TRPV1 | 14.5887 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PTAFR, RORC, TEK, TRPV1 | 13.3848 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PTAFR, RORC, SMAD3, TEK, TRPV1 | 13.1736 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PTAFR, RORC, TEK, TRPV1 | 13.1736 |
[MF] GO:0046914 | transition metal ion binding | ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH | 12.4949 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 12.0368 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PTAFR, TEK, TRPV1 | 11.9295 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PTAFR, TEK, TRPV1 | 11.9295 |
[MF] GO:0030594 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GRIA2, GRIA4, GRIK5, GRM1, GRM5 | 11.9295 |
[MF] GO:0043167 | ion binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTAFR, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TRPV1, TYR, XDH | 10.6413 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK, TRPV1 | 8.68132 |
[MF] GO:0008066 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 8.11872 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TYR, XDH | 8.0002 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 7.56227 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.19326 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 | 6.88177 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 6.61973 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 | 6.58925 |
[MF] GO:0005506 | iron ion binding | ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, XDH | 6.51095 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.48077 |
[MF] GO:0016907 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.46317 |
[MF] GO:0043169 | cation binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, ESR1, ESR2, F10, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, TRPV1, TYR, XDH | 6.38377 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH | 5.93304 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3 | 5.30608 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 | 5.29743 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.04108 |
[MF] GO:0042562 | hormone binding | ACHE, CHRM3, EGFR, HSD17B1, IGF1R, INSR, NR3C1 | 5.03579 |
[MF] GO:0004930 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GPR35, GRM1, GRM3, GRM5, GRM8, HCAR2, PTAFR | 4.93013 |
[MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, ESR2, F10, F3, FABP3, FABP4, HSD17B1, NR3C1, PPARA, PTAFR, RORC, TRPV1 | 4.8513 |
[MF] GO:0004952 | None | DRD1, DRD2, DRD3, DRD5 | 4.754 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, TYR | 4.754 |
[MF] GO:0035240 | None | DRD1, DRD2, DRD3, DRD5 | 4.61982 |
[MF] GO:0070405 | ammonium ion binding | ACHE, CHRM3, DRD1, DRD2, DRD3, DRD5 | 4.20768 |
[MF] GO:0015464 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.084 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 | 4.01724 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC | 3.98951 |
[MF] GO:1901338 | None | DRD1, DRD2, DRD3, DRD5 | 3.9053 |
[MF] GO:0005496 | steroid binding | CYP3A4, ESR1, ESR2, HSD17B1, NR3C1, RORC | 3.84232 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1, HSD17B2, XDH | 3.84232 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC | 3.80664 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.63193 |
[MF] GO:0046872 | metal ion binding | ALOX12, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, F10, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, TRPV1, TYR, XDH | 3.59527 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, TYR | 3.5182 |
[MF] GO:0008227 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD2 | 3.50987 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, NR3C1, PPARA, RORC | 3.45017 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.36528 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.36528 |
[MF] GO:0004629 | None | ADORA1, CHRM1, CHRM3, CHRM5 | 3.29677 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1, HSD17B2 | 3.15568 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2D6, CYP3A4 | 3.10207 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.97221 |
[MF] GO:0047977 | hepoxilin-epoxide hydrolase activity | ALOX12, ALOX15 | 2.97221 |
[MF] GO:0099528 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 2.94869 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 2.92681 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD17B1, SRC, XDH | 2.76108 |
[MF] GO:0005231 | None | GRIA2, GRIA4, GRIK5, TRPV1 | 2.60262 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 2.58485 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 2.5794 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, PPARA, RORC | 2.5794 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, PPARA, RORC | 2.5794 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.5794 |
[MF] GO:0004052 | arachidonate 12-lipoxygenase activity | ALOX12, ALOX15 | 2.5794 |
[MF] GO:0051120 | hepoxilin A3 synthase activity | ALOX12, ALOX15 | 2.5794 |
[MF] GO:0099583 | None | GRM1, GRM5 | 2.5794 |
[MF] GO:0019902 | phosphatase binding | EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 | 2.5062 |
[MF] GO:0004970 | None | GRIA2, GRIA4, GRIK5 | 2.49986 |
[MF] GO:0005234 | None | GRIA2, GRIA4, GRIK5 | 2.49986 |
[MF] GO:0043168 | anion binding | ALOX15, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTAFR, SLC1A1, SRC, TEK, TRPV1, XDH | 2.44662 |
[MF] GO:0031072 | heat shock protein binding | ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 | 2.44109 |
[MF] GO:0019900 | None | AURKB, CDC25B, DUSP3, EGFR, ESR1, GRM5, NR3C1, PTAFR, PTPN1, SMAD3, SRC | 2.39851 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC | 2.33402 |
[MF] GO:0001588 | None | DRD1, DRD5 | 2.33402 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.33402 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.33402 |
[MF] GO:0004971 | None | GRIA2, GRIA4 | 2.33402 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.33402 |
[MF] GO:0019901 | None | CDC25B, DUSP3, EGFR, ESR1, GRM5, NR3C1, PTAFR, PTPN1, SMAD3, SRC | 2.23125 |
[MF] GO:0042578 | None | ADORA1, ALPL, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 | 2.22484 |
[MF] GO:0035586 | None | ADORA1, ADORA3, PTAFR | 2.19359 |
[MF] GO:0099094 | None | GRIA2, GRIA4, GRIK5, TRPV1 | 2.18226 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX12, ALOX15, ALOX5 | 2.15846 |
[MF] GO:0101020 | estrogen 16-alpha-hydroxylase activity | CYP1A1, CYP3A4 | 2.15846 |
[MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.15846 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.15846 |
[MF] GO:0004435 | None | CHRM1, CHRM3, CHRM5 | 2.12273 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD17B1, HSD17B2 | 2.12273 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX12, ALOX15, ALOX5 | 2.12273 |
[MF] GO:0019838 | growth factor binding | EGFR, IGF1R, INSR, KDR, TEK | 2.08637 |
[MF] GO:0019899 | enzyme binding | AURKB, CDC25B, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, F3, GRM5, HMGCR, HSPA1A, MET, NR3C1, PPARA, PTAFR, PTPN1, SMAD3, SRC, TEK | 2.04219 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD17B1, HSD17B2 | 2.04219 |
[MF] GO:0043548 | phosphatidylinositol 3-kinase binding | AXL, IGF1R, INSR | 2.04219 |
[MF] GO:0004064 | arylesterase activity | CA1, CA2 | 2.01224 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 2.01045 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, GRIA2, CHRM3, CHRM1, GPR35, GRIK5, CHRM5, PTAFR, TRPV1, NR3C1, GRM1, GRM3, GRM5, ADORA3, GRM8, ADORA1, DRD1, DRD2, DRD3, DRD5, GRIA4 | 18.4892 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA6, CA9, CA14 | 13.083 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 8.961 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 8.5444 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 7.768 |
Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, CHRM3, GRM5, CHRM1, CHRM5, PTAFR, DRD1, GRM1, EGFR, DRD5 | 7.1798 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, ESR1, GRM1, EGFR, ESR2, HSPA1A | 6.8935 |
cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, HCAR2, GRIA2, CHRM1, ADORA1, DRD1, DRD2, PPARA, DRD5, GRIA4 | 6.8847 |
Glutamatergic synapse_Homo sapiens_hsa04724 | GRM3, GRIA2, GRM5, GRIK5, GRM8, SLC1A1, GRM1, GRIA4 | 6.5164 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, ESR1, EGFR, IGF1R | 4.7469 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP2D6, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 5.1473 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, INSR, KDR, TEK, DRD2, MET, EGFR, IGF1R | 4.6536 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 5.0757 |
Metabolic pathways_Homo sapiens_hsa01100 | ALOX15, AKR1B1, ALOX12, HMGCR, TYR, CYP3A4, CYP19A1, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, XDH | 4.1841 |
Gap junction_Homo sapiens_hsa04540 | GRM5, SRC, DRD1, DRD2, GRM1, EGFR | 4.7469 |
Dopaminergic synapse_Homo sapiens_hsa04728 | GRIA2, DRD1, DRD2, DRD3, DRD5, GRIA4 | 3.9045 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | GRM3, GRM5, INSR, GRM8, GRM1, EGFR | 3.6844 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, CHRM1, INSR, KDR, TEK, MET, EGFR, IGF1R | 3.2995 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.2385 |
Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE, CHRM3, CHRM1, CHRM5 | 3.2385 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 3.7592 |
Pathways in cancer_Homo sapiens_hsa05200 | SMAD3, FLT3, MMP1, MMP2, MMP9, MET, EGFR, IGF1R | 2.9416 |
Cocaine addiction_Homo sapiens_hsa05030 | GRM3, GRIA2, DRD1, DRD2 | 3.4521 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM3, CHRM1, SRC, CHRM5, EGFR | 2.9248 |
Ras signaling pathway_Homo sapiens_hsa04014 | INSR, KDR, TEK, MET, EGFR, IGF1R | 2.8024 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, INSR, GRM1, EGFR, IGF1R | 2.9416 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, MMP2, PIM1, F3 | 2.4619 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 2.969 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | GRIA2, GRM5, GRM1, GRIA4 | 2.4619 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIM1, CYP1B1, MMP9, MET, EGFR, CDC25B | 2.2729 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | INSR, TEK, EGFR, IGF1R | 2.4433 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, MET, EGFR, IGF1R | 2.257 |
Serotonergic synapse_Homo sapiens_hsa04726 | CYP2D6, ALOX5, ALOX15, ALOX12 | 2.3205 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, INSR, ADORA1 | 2.2172 |
Long-term depression_Homo sapiens_hsa04730 | GRIA2, GRM1, IGF1R | 2.1423 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | INSR, IGF1R, HSPA1A | 2.0841 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.7607 |
Amphetamine addiction_Homo sapiens_hsa05031 | GRIA2, DRD1, GRIA4 | 2.0686 |
Long-term potentiation_Homo sapiens_hsa04720 | GRIA2, GRM5, GRM1 | 2.0686 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, ALOX15, ALOX12 | 2.1126 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1 | 2.5542 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, EGFR | 1.7607 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET, EGFR | 2.0686 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, CYP3A4 | 2.0755 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC, ALOX12, TRPV1 | 1.6953 |
Melanoma_Homo sapiens_hsa05218 | MET, EGFR, IGF1R | 2.0347 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 2.0264 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.06 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, CDC25B, HSPA1A | 1.3177 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, INSR, PPARA | 1.5914 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2D6, CYP1A2, CYP3A4 | 2.0515 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, SRC, MMP9 | 1.2895 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.2815 |
AMPK signaling pathway_Homo sapiens_hsa04152 | INSR, HMGCR, IGF1R | 1.4553 |
Bile secretion_Homo sapiens_hsa04976 | CA2, HMGCR, CYP3A4 | 2.0347 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, INSR, ADORA1 | 1.1917 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4 | 2.9266 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3 | 0.1892 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC, EGFR | 1.0136 |
Prostate cancer_Homo sapiens_hsa05215 | EGFR, IGF1R | 1.0017 |
Taste transduction_Homo sapiens_hsa04742 | CHRM3, GRM1 | 1.0445 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.841 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | INSR, IGF1R | 0.9813 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 0.9658 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.841 |
Viral carcinogenesis_Homo sapiens_hsa05203 | SRC | 0.2473 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1 | 0.8336 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA, EGFR | 0.7775 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, HSPA1A | 0.841 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1, DRD1 | 0.9957 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, HSPA1A | 0.7755 |
Huntington's disease_Homo sapiens_hsa05016 | GRM5 | 0.2616 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2682 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2771 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | HSPA1A | 0.2834 |
Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.7667 |
Circadian entrainment_Homo sapiens_hsa04713 | GRIA2, GRIA4 | 0.9792 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.2766 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3, CDC25B | 0.8193 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 0.9987 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, INSR | 0.7688 |
Influenza A_Homo sapiens_hsa05164 | HSPA1A | 0.2771 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.2679 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.7688 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIM1 | 0.3011 |
Gastric acid secretion_Homo sapiens_hsa04971 | CHRM3, CA2 | 1.1169 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, IGF1R | 0.7667 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.3082 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 0.7667 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, HSPA1A | 0.5815 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | INSR, PPARA | 0.7359 |
Alcoholism_Homo sapiens_hsa05034 | DRD1, DRD2 | 0.6386 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.0814 |
Pancreatic secretion_Homo sapiens_hsa04972 | CHRM3, CA2 | 0.9763 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.3479 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC, EGFR | 0.7167 |
Glioma_Homo sapiens_hsa05214 | EGFR, IGF1R | 1.2017 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.3703 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3626 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F10, F3 | 1.0774 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3703 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.2399 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, EGFR | 1.1957 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4022 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3 | 0.4185 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.4256 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | EGFR | 0.4256 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4256 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.2815 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4377 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.2017 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1 | 0.442 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4512 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.4553 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4512 |
Salivary secretion_Homo sapiens_hsa04970 | CHRM3 | 0.4512 |
Insulin secretion_Homo sapiens_hsa04911 | CHRM3 | 0.4544 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4512 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.2602 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4562 |
Protein digestion and absorption_Homo sapiens_hsa04974 | SLC1A1 | 0.4506 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3 | 0.4968 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.4804 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5089 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5275 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5319 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5297 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3 | 0.5405 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | EGFR | 0.5759 |
Staphylococcus aureus infection_Homo sapiens_hsa05150 | PTAFR | 0.5759 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.5759 |
Endometrial cancer_Homo sapiens_hsa05213 | EGFR | 0.5896 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP3A4, XDH | 1.4292 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | GRIA2 | 0.5933 |
Malaria_Homo sapiens_hsa05144 | MET | 0.605 |
Nicotine addiction_Homo sapiens_hsa05033 | GRIA2, GRIA4 | 1.5308 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | INSR | 0.6092 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6135 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | INSR | 0.6796 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.734 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6038 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.7167 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.6953 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.7755 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.7167 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7518 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7775 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9363 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.7607 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7755 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | HMGCR | 0.8333 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.9813 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 2.9817 |